» Articles » PMID: 32164210

Endometrium-Limited Metastasis of Extragenital Malignancies: A Challenge in the Diagnosis of Endometrial Curettage Specimens

Overview
Specialty Radiology
Date 2020 Mar 14
PMID 32164210
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Malignancies of extragenital origin very rarely metastasize to the uterine body. Endometrium-limited metastases may pose diagnostic challenges in endometrial curettage specimens as they may be misdiagnosed as primary endometrial tumors. We investigated the clinicopathological characteristics of seven cases with endometrial-limited metastases from carcinomas of the nasopharynx ( = 1), breast ( = 2), colon ( = 2), stomach ( = 1), and appendix ( = 1). The patients' ages ranged from 36 to 71 (mean: 55.4) years. None of the patients had a remarkable gynecological history, and the presenting sign in all cases was abnormal uterine bleeding. Although myometrial involvement was absent, multiple metastases were already present in extrauterine locations such as the lung, liver, bone, abdominopelvic peritoneum, and omentum. All patients underwent ultrasonographic examination prior to endometrial curettage. The histologies of the endometrial metastases identified from the curettage specimens were identical to those of the corresponding primary tumors. Ancillary tests including immunostaining and Epstein-Barr virus-encoded RNA in situ hybridization confirmed the extragenital origin. Endometrium-limited metastases from extragenital malignancies are extremely rare. They present with abnormal vaginal bleeding and mimic endometrial carcinomas of endometrioid or poorly differentiated types. Since their clinical presentations and histological features are similar to those of primary endometrial tumors, pathologists should consider the possibility of metastases while evaluating endometrial curettage specimens obtained from patients with a history of extragenital malignancies.

Citing Articles

Endometrioid Carcinomas of the Ovaries and Endometrium Involving Endocervical Polyps: Comprehensive Clinicopathological Analyses.

Sohn J, Lee Y, Kim H Diagnostics (Basel). 2022; 12(10).

PMID: 36292027 PMC: 9600253. DOI: 10.3390/diagnostics12102339.


Alveolar Soft Part Sarcoma of the Uterus: Clinicopathological and Molecular Characteristics.

Lee Y, Na K, Woo H, Kim H Diagnostics (Basel). 2022; 12(5).

PMID: 35626258 PMC: 9139381. DOI: 10.3390/diagnostics12051102.


Mesonephric-like Adenocarcinoma of the Ovary: Clinicopathological and Molecular Characteristics.

Koh H, Park E, Kim H Diagnostics (Basel). 2022; 12(2).

PMID: 35204416 PMC: 8871294. DOI: 10.3390/diagnostics12020326.


Mesonephric-like Adenocarcinoma of the Uterine Corpus: Comprehensive Immunohistochemical Analyses Using Markers for Mesonephric, Endometrioid and Serous Tumors.

Kim H, Na K, Bae G, Kim H Diagnostics (Basel). 2021; 11(11).

PMID: 34829389 PMC: 8625485. DOI: 10.3390/diagnostics11112042.


Ovarian Mesonephric-like Adenocarcinoma With Multifocal Microscopic Involvement of the Fimbrial Surface: Potential for Misdiagnosis of Tubal Intraepithelial Metastasis as Serous Tubal Intraepithelial Carcinoma Associated With Ovarian High-grade....

Kim H, Bae G, Jung Y, Kim H In Vivo. 2021; 35(6):3613-3622.

PMID: 34697203 PMC: 8627772. DOI: 10.21873/invivo.12667.


References
1.
Sakaguchi M, Maebayashi T, Aizawa T, Ishibashi N . Whole-brain Radiation Therapy for Breast Cancer Patients with Dural Metastasis Without Concomitant Brain Metastasis and Leptomeningeal Metastasis. Anticancer Res. 2018; 38(11):6405-6411. DOI: 10.21873/anticanres.13001. View

2.
Boyd C, Cameron I, McCluggage W . Endometrial adenocarcinoma with signet ring cells: report of two cases of an extremely rare phenomenon. Int J Gynecol Pathol. 2010; 29(6):579-82. DOI: 10.1097/PGP.0b013e3181e20c66. View

3.
Hernandez B, Frierson H, Moskaluk C, Li Y, Clegg L, Cote T . CK20 and CK7 protein expression in colorectal cancer: demonstration of the utility of a population-based tissue microarray. Hum Pathol. 2005; 36(3):275-81. DOI: 10.1016/j.humpath.2005.01.013. View

4.
Lee J, Chung Y, Na K, Kim H, Park C, Nam E . External validation of chemotherapy response score system for histopathological assessment of tumor regression after neoadjuvant chemotherapy in tubo-ovarian high-grade serous carcinoma. J Gynecol Oncol. 2017; 28(6):e73. PMC: 5641524. DOI: 10.3802/jgo.2017.28.e73. View

5.
Kim E, Yoon G, Kim H . Chemotherapy-induced endometrial pathology: mimicry of malignancy and viral endometritis. Am J Transl Res. 2016; 8(5):2459-67. PMC: 4891460. View